Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, and Essential Oils), Livestock (Poultry, Swine, Ruminants, and Aquatic animals), Function (Nutrition & Gut Health, Yield, Immunity, and Production), and Dosage Form (Dry, and Liquid) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Medical Devices & Supplies	LI_183513	Pages: NA	Jun 2019 \| 929 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Eubiotics refers to the science of healthy living. Eubiotics ensures that a healthy balance of micro-flora is maintained in the gastrointestinal tract of an animal.

The global eubiotics market is driven by several factors such as rise in awareness about feed quality & safety, rising demand for manufactured animal feed, increasing trend of replacing antibiotic growth promoters (AGPS) with eubiotics, and growth in the demand for animal protein. However, complexities of food production chains and strict regulations for trade of eubiotics will restrain the market growth. Increasing investments in the animal nutrition sector and increase in awareness about eubiotics will provide opportunities for the market growth.

The report segments the global eubiotics market based on type, livestock, function, dosage form, and region. Based on type, it is divided into probiotics, prebiotics, organic acids, and essential oils. Based on livestock, it is segmented into poultry, swine, ruminants, and aquatic animals. Based on function, it is divided into nutrition & gut health, yield, immunity, and production. Based on dosage form, it is bifurcated into dry and liquid. Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players that operate in the market include Cargill, Incorporated, BASF SE, E. I. du Pont de Nemours and Company, Koninklijke DSM N.V., Novozymes, Kemin Industries, Inc., and Calpis Co., Ltd.

Key Benefits

The study provides an in-depth analysis of the global market with current trends and future estimations to elucidate imminent investment pockets.
The report provides a quantitative analysis from 2016 to 2023, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions has been provided that helps determine prevailing opportunities in these regions.
Key market players within the market have been profiled in the report and their strategies thoroughly analyzed, which helps understand the competitive outlook of the global market.
Extensive analysis of the market has been conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Eubiotics Market Key Segments:

By Type

Probiotics
Prebiotics
Organic Acids
Essential Oils

By Livestock

Poultry
Swine
Ruminants
Aquatic Animals

By Function

Nutrition & Gut Health
Yield
Immunity
Production

By Dosage Form

Dry
Liquid

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 EUBIOTICS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PROBIOTICS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. PREBIOTICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. ORGANIC ACIDS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. ESSENTIAL OILS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

Chapter: 5 EUBIOTICS MARKET, BY LIVESTOCK

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. POULTRY

5.2.1. Market size and forecast

5.3. SWINE

5.3.1. Market size and forecast

5.4. RUMINANTS

5.4.1. Market size and forecast

5.5. AQUATIC ANIMALS

5.5.1. Market size and forecast

Chapter: 6 EUBIOTICS MARKET, BY FUNCTION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NUTRITION AND GUT HEALTH

6.2.1. Market size and forecast

6.3. YIELD

6.3.1. Market size and forecast

6.4. IMMUNITY

6.4.1. Market size and forecast

6.5. PRODUCTION

6.5.1. Market size and forecast

Chapter: 7 EUBIOTICS MARKET, BY DOSAGE FORM

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. DRY

7.2.1. Market size and forecast

7.3. LIQUID

7.3.1. Market size and forecast

Chapter: 8 EUBIOTICS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America Eubiotics Market by Type
8.2.5. North America Eubiotics Market by Livestock
8.2.6. North America Eubiotics Market by Function
8.2.7. North America Eubiotics Market by Dosage Form
8.2.8. North America Eubiotics Market by Application

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe Eubiotics Market by Type
8.3.5. Europe Eubiotics Market by Livestock
8.3.6. North America Eubiotics Market by Function
8.3.7. Europe Eubiotics Market by Dosage Form
8.3.8. Europe Eubiotics Market by Application

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific Eubiotics Market by Type
8.4.5. Asia-Pacific Eubiotics Market by Livestock
8.4.6. Asia-Pacific Eubiotics Market by Function
8.4.7. Asia-Pacific Eubiotics Market by Dosage Form
8.4.8. Asia-Pacific Eubiotics Market by Application

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

8.5.4. LAMEA Eubiotics Market by Type
8.5.5. LAMEA Eubiotics Market by Livestock
8.5.6. LAMEA Eubiotics Market by Function
8.5.7. LAMEA Eubiotics Market by Dosage Form
8.5.8. LAMEA Eubiotics Market by Application

Chapter: 9 COMPANY PROFILES

9.1. BASF SE

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. CARGILL, INC.

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. E. I. DU PONT DE NEMOURS AND COMPANY

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. KONINKLIJKE DSM N.V.

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. CHR. HANSEN A/S

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. ASAHI GROUP HOLDINGS, LTD.

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. NOVOZYMES

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. LESAFFRE

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. LALLEMAND INC.

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. KEMIN INDUSTRIES, INC.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Eubiotics Market Key Segments:

By Type

By Livestock

By Function

By Dosage Form

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept